InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
2 hedge funds and large institutions have $36K invested in InspireMD, Inc. Warrants in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
12% less capital invested
Capital invested by funds: $41K → $36K (-$5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$28 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $36K | -$28 | -852 | -0.1% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$41 | +1,275 | +14% |
|
NSPRW Hedge Fund Activity: Q4 2017 in Review
2 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q4 2017, worth a combined $36K — down 12% from $41K a quarter earlier.
Fund positioning in NSPRW was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $41. The largest seller was Sabby Management, cutting an estimated $28.
- 2 institutional investors held InspireMD, Inc. Warrants (NSPRW) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $36K of InspireMD, Inc. Warrants stock for Q4 2017, down 12% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q4 2017 and 0 closed out.
- The largest InspireMD, Inc. Warrants buyer in Q4 2017 was UBS Group, an estimated $41 added.
- The largest InspireMD, Inc. Warrants seller in Q4 2017 was Sabby Management, an estimated $28 sold.
Based on aggregated 13F filings for Q4 2017.